Koyfin Home > Directory > Health Care > Adamas Pharma > Total Debt / Equity

Adamas Pharma Total Debt / Equity Chart (ADMS)

Adamas Pharma annual/quarterly Total Debt / Equity from 2012 to 2020. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Adamas Pharma Total Debt / Equity for the quarter ending June 06, 2020 was $-561m a 222.73% decrease of -1,249m year over year
  • Adamas Pharma Total Debt / Equity for the last 12 months ending June 06, 2020 was $-561m a 222.73% decrease of -1,249m year over year
  • Adamas Pharma Annual Total Debt / Equity for 2019 was $-15,415m a 100.86% decrease of -15,548m from 2018
  • Adamas Pharma Annual Total Debt / Equity for 2018 was $133m a -17.13% decrease of -23m from 2017
  • Adamas Pharma Annual Total Debt / Equity for 2017 was $155m a 90.02% increase of 140m from 2016
Other Ratios Metrics:
  • Adamas Pharma Total Debt / Capital for the quarter ending September 09, 2018 was $50m a -21.13% decrease of -11m year over year
  • Adamas Pharma Other Liabilities for the quarter ending December 12, 2018 was $3m a 76.22% increase of 2m year over year
View Chart On Koyfin

Quarterly ADMS Total Debt / Equity Data

06/2020$-561m
03/2020$-865m
12/2019$-15,415m
09/2019$688m
06/2019$312m
03/2019$204m
12/2018$133m
09/2018$101m
06/2018$78m
03/2018$63m

Annual ADMS Total Debt / Equity Data

2019$-15,415m
2018$133m
2017$155m
2012$15m